Agomelatine in treating generalized anxiety disorder

Agomelatine Prevents Relapse in Generalized Anxiety Disorder

(2012) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Agomelatine: A narrative review

(2011) Koen Demyttenaere   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The size and burden of mental disorders and other disorders of the brain in Europe 2010

(2011) H.U. Wittchen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V

(2010) Gavin Andrews et al.   DEPRESSION AND ANXIETY

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

(2010) Siegfried Kasper et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder

(2009) R. Bruce Lydiard et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Eszopiclone Coadministered With Escitalopram in Patients With Insomnia and Comorbid Generalized Anxiety Disorder

(2008) Mark Pollack et al.   ARCHIVES OF GENERAL PSYCHIATRY

The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats

(2008) Lisa Conboy et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy of Agomelatine in Generalized Anxiety Disorder

(2008) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY